Moderna, Inc.

MRNA

Healthcare

$48.91+4.71%vs prev close

$22.28

$59.55

52W Range

+1.27 (+2.53%)Past 1M

Price

Stock Timeline

Institutional Holders

2 Holding · 1 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Philippe LaffontCoatue Management

New Buy

200,000

Portfolio Weight

0.17%

Est. Value

$6M

Change

New position

Ray DalioBridgewater Associates

Decreased

15,181

Portfolio Weight

Est. Value

$448K

vs Prev Quarter

-93% (222K→15K)

Sold · Q4 2025

Cathie WoodARK Invest

Fully Sold

Portfolio Weight

Prev Holdings

Est. Sold Value

$3K

Holding Period

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Targets

avg.

$43.37

vs Current ▼ -11.3% downside

Current$48.91

Low ~ High$21.00 ~ $69.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

UBS

Neutral

$45.00

-7.99%

$47.30

Maintain

2026-05-04

Goldman Sachs

Neutral

$49.00

+0.18%

$47.30

Maintain

2026-05-04

Evercore ISI Group

In-Line

$50.00

+2.23%

$47.30

Maintain

2026-05-04

RBC Capital

Sector Perform

$38.00

-22.31%

$47.30

Maintain

2026-05-04

Barclays

Equal-Weight

$48.00

-1.86%

$49.20

Maintain

2026-04-02

1 / 1

Avg Target

$43.37

vs Current ▼ -11.3% downside

Hold

23 analysts

Strong Buy 2Buy 2Hold 16Sell 1Strong Sell 2

Low $21.00

Current $48.91

High $69.00

Firm	Position	Target	Upside	Close	Action	Date
UBS	Neutral	$45.00	-7.99%	$47.30	Maintain	26.05.04
Goldman Sachs	Neutral	$49.00	+0.18%	$47.30	Maintain	26.05.04
Evercore ISI Group	In-Line	$50.00	+2.23%	$47.30	Maintain	26.05.04
RBC Capital	Sector Perform	$38.00	-22.31%	$47.30	Maintain	26.05.04
Barclays	Equal-Weight	$48.00	-1.86%	$49.20	Maintain	26.04.02

1 / 1

Price Information

Previous Close$46.71

Open$47.00

Day Range$46.73 - $49.05

52-Week Range$22.28 - $59.55

1-Year Change94.14%

Trading Volume

Volume3,284,978

Avg Volume (3mo)7,862,431

Valuation

Market Cap19.4B

Book Value$21.95

Shares Outstanding396,786,259

Financials

Revenue (TTM)2.2B

Net Income-3,193,999,872

EPS$-8.14

EBITDA-2,299,000,064

Profitability

P/E Ratio-

P/B Ratio2.23

Return on Equity (ROE)-36.56%

Return on Assets (ROA)-13.09%

Profit Margin-143.55%

EV/EBITDA-6.36

Beta1.06

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)34.78

Company Overview

Moderna, Inc. is a biotechnology company that develops and commercializes messenger RNA (mRNA) medicines. Its main products include respiratory vaccines like Spikevax (COVID-19) and mRESVIA (RSV), as well as vaccines for latent viruses, enteric viruses, public health threats, and bacterial diseases. Moderna also offers oncology therapeutics and rare disease treatments, positioning itself as a leader in mRNA-based therapies.

P/B

2.23

Price-to-Book

ROE

-36.6%

Persistent loss

Beta

1.06

Market Volatility

RSI(14)

34.8

Neutral zone

AI-generated summary. Not investment advice.